[144] ANI Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

ANI Pharmaceuticals (ANIP) Form 144 shows a proposed sale of 14,675 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $1,304,170.19, and an approximate sale date of 08/18/2025. The issuer has 21,688,772 shares outstanding. The filing lists acquisition details for the securities being sold: 1,072 shares vested 12/20/2021, 3,554 shares vested 08/31/2022, and 10,049 shares vested 05/09/2023, all described as restricted stock vesting under a registered plan for services rendered. The filing also records a sale on 08/18/2025 by Jeanne A Thoma of 6,865 shares for gross proceeds of $616,223.68. The filer attests there is no undisclosed material adverse information.

Positive

• Full acquisition history provided showing vesting dates and amounts for the shares to be sold
• Broker and estimated market value disclosed, improving transparency about the proposed sale
• Seller attestation that no undisclosed material adverse information is known

Negative

• None.

Insights

Securities Analyst

TL;DR Insider proposes to sell vested restricted shares; transaction appears routine and consistent with employment-related equity vesting.

The filing documents a routine Rule 144 notice for the proposed sale of 14,675 ANIP common shares via Morgan Stanley with an indicated aggregate market value of $1,304,170.19 and an approximate sale date of 08/18/2025. Acquisition history shows these shares resulted from restricted stock vesting under a registered plan and were granted as consideration for services, which aligns with standard executive/employee equity compensation patterns. The contemporaneous record of a separate sale by Jeanne A Thoma of 6,865 shares for $616,223.68 is disclosed. There is no information here about any undisclosed material events or change in issuer fundamentals; the filing is procedural under Rule 144.

Corporate Governance Expert

TL;DR Equity dispositions tied to vesting are disclosed appropriately; no governance concerns are evident from this filing alone.

The Form 144 specifies that the securities to be sold were acquired through restricted stock vesting under a registered plan with payment characterized as services rendered, indicating standard compensation practice. The notice includes broker details and an attestation that the seller is unaware of undisclosed material adverse information. Absent additional disclosures about related-party transfers, accelerated vesting, or unusual timing around material events, this filing presents as a routine insider disclosure rather than a governance red flag.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14675	1304170.19	21688772	08/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/20/2021	Restricted stock vesting under a registered plan	Issuer			1072	12/20/2021	Services Rendered
Common	08/31/2022	Restricted stock vesting under a registered plan	Issuer			3554	08/31/2022	Services Rendered
Common	05/09/2023	Restricted stock vesting under a registered plan	Issuer			10049	05/09/2023	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JEANNE A THOMA 210 Main Street West Baudette MN 56623	Common	08/18/2025	6865	616223.68

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities does the ANIP Form 144 propose to sell?

The filing proposes sale of 14,675 shares of ANIP common stock with an aggregate market value of $1,304,170.19.

When is the approximate sale date listed on the ANIP Form 144?

The filing lists an approximate sale date of 08/18/2025.

How were the ANIP shares being sold acquired?

The shares were acquired via restricted stock vesting under a registered plan on 12/20/2021 (1,072 shares), 08/31/2022 (3,554 shares), and 05/09/2023 (10,049 shares).

Who is the broker handling the proposed ANIP sale?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza 8th Floor New York NY 10004.

Did the filer report any recent sales of ANIP shares?

Yes. The filing records that Jeanne A Thoma sold 6,865 shares on 08/18/2025 for gross proceeds of $616,223.68.